NI
Nika Pharmaceuticals Inc.
NIKA · OTC
$0.41 +0.00% (+$0.00)
Market Cap $429.9M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.36
12.2% downside
Current Price
$0.41
Undervalued Fair Value Overvalued
According to Bulios Fair Price, NIKA is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
57 /100
Average ROIC 23.63%
ROA 785.81%
Asset turnover 0.00x
Debt
0 /100
High Current ratio 0.03x
Debt/Equity N/A
Int. coverage N/A
Stability
32 /100
Unstable Beta -2.48x
EPS volatility 56.13%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NIKA
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Dimitar Slavchev Savov
Employees
0
Headquarters
Henderson